
Sign up to save your podcasts
Or
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
3.7
5353 ratings
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
132 Listeners
322 Listeners
160 Listeners
862 Listeners
496 Listeners
272 Listeners
3,321 Listeners
87 Listeners
135 Listeners
1,081 Listeners
39 Listeners
186 Listeners
321 Listeners
416 Listeners
35 Listeners